Harborside Press

SHERPA: Unknown

People

  1. Saltz
    Saltz
  2. Zelenetz
    Zelenetz
  3. Yahalom
    Yahalom
  4. Abu-Rustum
    Abu-Rustum
  5. Riely
    Riely
  6. Sofocleous
    Sofocleous
  7. Shah
    Shah
  8. Motzer
    Motzer
  9. McCormick
    McCormick
  10. Pfister
    Pfister

Groups

  1. Department of Medicine (407)
  2. Solid Tumor Oncology Division (241)
  3. Surgery (167)
  4. Survivorship Research (135)
  5. Hematologic Malignancies, Division of (122)
  6. Center for Hematologic Malignancies (111)
  7. Population Sciences Research Program (99)
  8. Division of Subspecialty Medicine (75)
  9. Gastrointestinal Oncology Service (74)
  10. Radiation Oncology, Department of (71)
Search Within
Formats
  1. Journal Article (477)
  2. Guidelines (149)
  3. Review (35)
  4. Editorial (17)
  5. Conference Paper (10)
  6. Meeting Abstract (7)
  7. Correspondence (2)
Groups
  1. Department of Medicine (407)
  2. Solid Tumor Oncology Division (241)
  3. Surgery (167)
  4. Survivorship Research (135)
  5. Hematologic Malignancies, Division of (122)
  6. Center for Hematologic Malignancies (111)

More Groups

People
  1. Leonard Saltz (42)
  2. Andrew Zelenetz (35)
  3. Joachim Yahalom (31)
  4. Nadeem Abu-Rustum (26)
  5. Gregory Riely (25)
  6. Constantinos Sofocleous (22)

More People

Years
  1. 2025 (16)
  2. 2024 (38)
  3. 2023 (32)
  4. 2022 (43)
  5. 2021 (46)
  6. 2020 (35)

More Years

Publications
  1. Journal of the National Comprehensive Cancer Network (673)
  2. Journal of the Advanced Practitioner in Oncology (23)
  3. The ASCO Post (1)

Results (697)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NCCN Guidelines® Insights: Lung cancer screening, version 1.2022: Featured updates to the NCCN Guidelines
    Guidelines

    Wood, D. E.; Kazerooni, E. A.; Aberle, D.; Berman, A.; Brown, L. M.; Eapen, G. A.; Ettinger, D. S.; Ferguson, J. S.; Hou, L.; Kadaria, D.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • The risk of opportunistic infections and the role of antibiotic prophylaxis in patients on checkpoint inhibitors requiring steroids
    Journal Article

    Shah, N. J.; Cook, M. R.; Wu, T.; Lev-Ari, S.; Blackburn, M. J.; Serzan, M. T.; Alaoui, A.; Ahn, J.; Atkins, M. B.
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
    Guidelines

    von Mehren, M.; Kane, J. M. 3rd; Agulnik, M.; Bui, M. M.; Carr-Ascher, J.; Choy, E.; Connelly, M.; Dry, S.; Ganjoo, K. N.; Gonzalez, R. J.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Breast cancer, version 3.2022: NCCN Practice Guidelines in Oncology
    Guidelines

    Gradishar, W. J.; Moran, M. S.; Abraham, J.; Aft, R.; Agnese, D.; Allison, K. H.; Anderson, B.; Burstein, H. J.; Chew, H.; Dang, C.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 3.2022: Featured updates to the NCCN Guidelines
    Guidelines

    Wierda, W. G.; Brown, J.; Abramson, J. S.; Awan, F.; Bilgrami, S. F.; Bociek, G.; Brander, D.; Chanan-Khan, A. A.; Coutre, S. E.; Davis, R. S.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Costs and barriers of cancer screening after positive genetic testing: Are actionable mutations becoming unactionable?
    Editorial

    Kahn, R. M.; Gordhandas, S.; Aviki, E.; Long Roche, K.
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Implementing a clinical decision tool to improve oncologic venous thromboembolism management
    Journal Article

    Majeed, J.; Turner, B. S.; Kelly, D.; Poon, C.; Thompson, J. A.; Barrett, J.; Soff, G. A.
    Journal of the Advanced Practitioner in Oncology (2022)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Hodgkin lymphoma, version 2.2022: Featured updates to the NCCN Guidelines
    Guidelines

    Hoppe, R. T.; Advani, R. H.; Ai, W. Z.; Ambinder, R. F.; Armand, P.; Bello, C. M.; Benitez, C. M.; Chen, W.; Dabaja, B.; Daly, M. E.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Management of immunotherapy-related toxicities, version 1.2022: NCCN Clinical Practice Guidelines in Oncology
    Guidelines

    Thompson, J. A.; Schneider, B. J.; Brahmer, J.; Achufusi, A.; Armand, P.; Berkenstock, M. K.; Bhatia, S.; Budde, L. E.; Chokshi, S.; Davies, M.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Hematopoietic growth factors, version 1.2022: Featured updates to the NCCN Guidelines
    Guidelines

    Griffiths, E. A.; Roy, V.; Alwan, L.; Bachiashvili, K.; Baird, J.; Cool, R.; Dinner, S.; Geyer, M.; Glaspy, J.; Gojo, I.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save